Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Malignant Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03890731
What this trial is testing

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Who this might be right for
Solid Cancer
Bayer 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783153
What this trial is testing

Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients

Who this might be right for
Radiotherapy Induced DiarrheaAcute Radiation EnteritisProstate Cancer+5 more
Mansoura University 80
Large-scale testing (Phase 3)Active Not RecruitingNCT01349881
What this trial is testing

S0820, Adenoma and Second Primary Prevention Trial

Who this might be right for
Colorectal Neoplasms
SWOG Cancer Research Network 354
Not applicableWithdrawnNCT03413930
What this trial is testing

Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Who this might be right for
Rectal Cancer
Ruijin Hospital
Testing effectiveness (Phase 2)Ended earlyNCT01508000
What this trial is testing

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

Who this might be right for
Colorectal Cancer MetastaticLiver MetastasesKRAS Wild Type Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Post-approval studies (Phase 4)Study completedNCT02567331
What this trial is testing

Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 28
Not applicableUnknownNCT02553031
What this trial is testing

Application of MR-PET in Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07025239
What this trial is testing

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Looking for participantsNCT07728019
What this trial is testing

Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM

Who this might be right for
CRC (Colorectal Cancer)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Not applicableWithdrawnNCT03633539
What this trial is testing

Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Who this might be right for
Colorectal CancerColonic NeoplasmsRectal Neoplasms+4 more
Ruijin Hospital
Large-scale testing (Phase 3)Study completedNCT01607957
What this trial is testing

Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies

Who this might be right for
Colorectal Cancer
Taiho Oncology, Inc. 800
Not applicableStudy completedNCT02022553
What this trial is testing

Procedure RACHEL in Complex Treatment of Rectal Cancer

Who this might be right for
Rectal Cancer T3-4N0-2M0
Voronezh N.N. Burdenko State Medical Academy 52
Early research (Phase 1)Study completedNCT00967577
What this trial is testing

177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors

Who this might be right for
Kidney CancerHead and Neck CancerBreast Cancer+6 more
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06589830
What this trial is testing

TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticAdvanced Colorectal Cancer
Suzhou Teligene Ltd. 80
Testing effectiveness (Phase 2)UnknownNCT01237665
What this trial is testing

IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer

Who this might be right for
Rectal Cancer
Ottawa Hospital Research Institute 15
Not applicableStudy completedNCT02027545
What this trial is testing

Promoting Veteran-Centered Colorectal Cancer Screening

Who this might be right for
Colorectal Cancer
VA Office of Research and Development 436
Not applicableLooking for participantsNCT05523245
What this trial is testing

Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 1,700
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399757
What this trial is testing

Investigate APL-5125 in Adults With Advanced Solid Tumors

Who this might be right for
Colorectal CancerCholangiocarcinomaAppendiceal Adenocarcinoma+6 more
Apollo Therapeutics Ltd 100
Large-scale testing (Phase 3)Looking for participantsNCT07549412
What this trial is testing

Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

Who this might be right for
Metastatic Colorectal Cancer
EMD Serono Research & Development Institute, Inc. 1,020
Not applicableStudy completedNCT04430231
What this trial is testing

Does Delaying Curative Surgery for Colorectal Cancer Influence Long-term Disease Free Survival.

Who this might be right for
Colorectal Cancer
Fundación para la Investigación del Hospital Clínico de Valencia 602
Next Page